Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

Morgan Stanley Maintains Underweight on Virtus Inv, Raises Price Target to $180

Author: Benzinga Newsdesk | October 06, 2025 09:55am
Morgan Stanley analyst Michael Cyprys maintains Virtus Inv (NYSE:VRTS) with a Underweight and raises the price target from $170 to $180.

Posted In: VRTS

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist